Literature DB >> 12080423

Selection of microbial consortia for treating metal-working fluids.

C J van der Gast1, C J Knowles, M Starkey, I P Thompson.   

Abstract

The aim of this research was to determine the effectiveness of a strategy for constructing microbial consortia for treating chemically mixed industrial effluent, based on a more thorough understanding of communities within waste metal-working fluids (MWFs). Complementary phenotypic and genotypic methods revealed that the microbial communities in spent MWFs had low diversity and were very similar in species composition in samples originating from different locations and uses. Of 65 bacterial isolates studied, only 9 species were identified using fatty acid methyl ester (FAME) analysis. The results of genotypic analysis by denaturing gradient gel electrophoresis (DGGE) were congruent with observations made using FAME analysis. The metabolic potential of the isolates was assessed in terms of assimilation ability and tolerance of co-contaminants. The three isolates, selected (Clavibacter michiganensis, Methylobacterium mesophilicum, and Rhodococcus erythropolis) to form a consortium, were representative of three of the four most abundant populations and when combined could utilise or tolerate all of the individual MWF components, including the biocide and the recalcitrant compound benzotriazole.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080423     DOI: 10.1038/sj.jim.7000271

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  2 in total

1.  Toxicity drives facilitation between 4 bacterial species.

Authors:  Philippe Piccardi; Björn Vessman; Sara Mitri
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-03       Impact factor: 11.205

2.  Flow cytometry, a powerful novel tool to rapidly assess bacterial viability in metal working fluids: Proof-of-principle.

Authors:  Donna Vanhauteghem; Kris Audenaert; Kristel Demeyere; Fred Hoogendoorn; Geert P J Janssens; Evelyne Meyer
Journal:  PLoS One       Date:  2019-02-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.